Michael Liu, MD
Specialty: Colon and Rectal Surgery
Michael Liu, MD is a board-certified colorectal surgeon at University Hospitals and a clinical assistant professor at Case Western Reserve University School of Medicine. He is also an active member of the American College of Surgeons and the American Society for Colon and Rectal Surgeons.
Dr. Liu’s special clinical interests include colon cancer, rectal cancer, inflammatory bowel disease (Crohn’s disease and ulcerative colitis), diverticulitis, minimally invasive/laparoscopic surgery and colonoscopy.
After receiving his undergraduate degree in biological sciences at the University of Chicago, Dr. Liu attended the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University where he earned his medical doctorate with a special qualification in biomedical research. After a general surgery residency at the Cleveland Clinic, Dr. Liu further advanced his training by completing a colorectal surgery fellowship, also at the Cleveland Clinic. In addition, he completed a research fellowship at Washington University in Saint Louis School of Medicine as the Doris Duke Clinical Research Fellow. He joined the medical staff at UH in 2020.
Dr. Liu is a highly accomplished presenter and researcher. He has authored and co-authored numerous peer-reviewed publications and abstracts and has presented his findings at national and international professional symposiums and conferences. Dr. Liu’s research interests include both basic science and clinical outcomes.
A resident of Westlake, Dr. Liu enjoys spending his free time with his family.
Certifications & Memberships
- Colon and Rectal Surgery - American Board of Colon and Rectal Surgery
- Surgery - American Board of Surgery
Fellowship | Colon and Rectal Surgery
Colon and Rectal Surgery - Cleveland Clinic (2016 - 2017)
Residency | General Surgery
General Surgery - Cleveland Clinic (2011 - 2016)
Case Western Reserve University School Of Medicine (2011)
University Of Chicago (2003)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Michael Liu did not disclose any Outside Relationships with Industry.